Fauci says Pfizer is on its way to vaccine promoters in the United States

WASHINGTON, Sept. 5 (Reuters) – U.S. leading infectious disease expert Dr. Anthony Fauci said Sunday that officials are likely to soon get regulatory approval to administer the COVID-19 vaccine booster vaccines made by Pfizer (PFE.N), although Modern Boost (MRNA.O) may take little more.

Asked on CBS’s “Face the Nation” about President Joe Biden’s goal of giving reinforcements from Sept. 20, Fauci said “in some respects” the plan remained.

But he said that although Pfizer-BioNTech has submitted the necessary data on booster shots to the Food and Drug Administration (FDA), Moderna has not yet completed the process. Fauci said he hopes to administer the two vaccines when booster doses are released, but if Moderna does not complete the process before Sept. 20, they will be given later.

Moderna and the FDA did not immediately return emails requesting comments. In a statement released Wednesday, Moderna said it had “begun filing” reinforcing data with the FDA.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during a hearing on the Senate Committee on Health, Education, Work and Pensions in the Dirksen Senate Office building in Washington , DC, USA, July 20, 2021. Stefani Reynolds / Pool via REUTERS

How to administer reinforcements, or even if, has become a thorny issue, as COVID-19 continues to kill unvaccinated people around the world. Read more

Last month, the Biden administration announced that it would begin offering boosters to Americans on September 20, usurping the process by which the FDA and the U.S. Centers for Disease Control and Prevention often decide on these issues, Current and former FDA scientists and members of the CDC advisory panel have told Reuters.

Scientists are still debating how much additional immune boosters they provide and whether all Americans should receive another vaccine, rather than just those at high risk for serious illness.

In statements on Sunday, Fauci stressed that both boosters were supposed to be safe, but that the FDA and other officials would study the data to make sure.

“When it comes to allowing the American public to receive an intervention, you want to make sure it’s absolutely safe,” he said.

Report by Raphael Satter; Edited by Lisa Shumaker

Our standards: the principles of trust of Thomson Reuters.

.Source